in vitro and in vivo Photodynamic Activity Study of U-87 Human Glioma Cell with Photofrin

실험관 및 생체내에서 U-87 교모세포종 세포주의 광역학 치료 효과에 대한 연구

  • Cho, Woo Jin (Catholic Neuroscience Center, Department of Neurosurgery, The Catholic University College of Medicine) ;
  • Cho, Kyung-Keun (Catholic Neuroscience Center, Department of Neurosurgery, The Catholic University College of Medicine) ;
  • Ji, Cheol (Catholic Neuroscience Center, Department of Neurosurgery, The Catholic University College of Medicine) ;
  • Park, Sung Chan (Catholic Neuroscience Center, Department of Neurosurgery, The Catholic University College of Medicine) ;
  • Park, Hea Kwan (Catholic Neuroscience Center, Department of Neurosurgery, The Catholic University College of Medicine) ;
  • Kang, Joon Ki (Catholic Neuroscience Center, Department of Neurosurgery, The Catholic University College of Medicine) ;
  • Choi, Chang Rak (Catholic Neuroscience Center, Department of Neurosurgery, The Catholic University College of Medicine)
  • 조우진 (가톨릭 뇌신경센터, 가톨릭대학교 의과대학 신경외과학교실) ;
  • 조경근 (가톨릭 뇌신경센터, 가톨릭대학교 의과대학 신경외과학교실) ;
  • 지철 (가톨릭 뇌신경센터, 가톨릭대학교 의과대학 신경외과학교실) ;
  • 박성찬 (가톨릭 뇌신경센터, 가톨릭대학교 의과대학 신경외과학교실) ;
  • 박해관 (가톨릭 뇌신경센터, 가톨릭대학교 의과대학 신경외과학교실) ;
  • 강준기 (가톨릭 뇌신경센터, 가톨릭대학교 의과대학 신경외과학교실) ;
  • 최창락 (가톨릭 뇌신경센터, 가톨릭대학교 의과대학 신경외과학교실)
  • Received : 2000.07.04
  • Accepted : 2001.02.20
  • Published : 2001.05.28

Abstract

Objective : The objective of this study was to determine the photodynamic therapeutic response of U-87 human glioma cell in vitro as well as in the nude rat xenograft model using photofrin as photosensitizer. Material and Method : U-87 cells were cultured on 96-well culture plates, photofrin(Quadralogic Technologies Inc., Vancouver, Canada) was added into the cell culture medium at concentration of $1{\mu}g/ml$, $2.5{\mu}g/ml$, $5{\mu}g/ml$, $10{\mu}g/ml$ and $20{\mu}g/ml$. 24 hour after drug treatment, cells were treated with optical(632nm) irradiation of $100mJ/cm^2$, $200mJ/cm^2$ and $400mJ/cm^2$. Photofrin(12.5mg/kg, i.p.) was administered to 28 nude rats containing intracerebral U-87 human glioma as well as 26 normal nude rats. 48 hours after administration, animals were treated with optical irradiation(632nm) of $35J/cm^2$, $140J/cm^2$ and $280J/cm^2$ to exposed tumor and normal brain. The photofrin concentration was measured in tumor and normal brain in a separate population of animals. Results : By MTT assay, there was 100% cytotoxicity at any dose of photofrin with optical irradiation of $200mJ/cm^2$ and $400mJ/cm^2$. But at the optical irradiation of $100mJ/cm^2$ cells were killed in dose dependent manner 28.5%, 49.1%, 54.4%, 78.2%, and 84.6% at concentration of $1{\mu}g/ml$, $2.5{\mu}g/ml$, $5{\mu}g/ml$, $10{\mu}g/ml$ and $20{\mu}g/ml$, respectively. Dose dependent PDT lesions in both tumor and normal brain were observed. In the tumor lesion, only superficial tissue damage was found with optical irradiation of $35J/cm^2$. However, in the optical irradiation group of $140J/cm^2$ and $280J/cm^2$ the volume of lesions was measured of $7.2mm^3$ and $14.0mm^3$ for treatment at $140J/cm^2$ and $280J/cm^2$, respectively. The U-87 bearing rats showed a photofrin concentration in tumor tissue of $6.53{\pm}2.16{\mu}g/g$, 23 times higher than that found in the contralateral hemisphere of $0.28{\pm}0.15{\mu}g/g$. Conclusion : Our data indicate that the U-87 human glioma in vitro and in the xenografted rats is responsive to PDT. At these doses, a reproducible injury can be delivered to human glioma in this model. Strategies to spare the normal brain collateral damage are being studied.

Keywords